These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Differentiation anomaly of tumor cells and enzymes]. Tsuiki S Naika; 1971 Oct; 28(4):604-8. PubMed ID: 4943162 [No Abstract] [Full Text] [Related]
4. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Bergers G; Hanahan D; Coussens LM Int J Dev Biol; 1998; 42(7):995-1002. PubMed ID: 9853830 [TBL] [Abstract][Full Text] [Related]
6. Experimental systems for analysis of the surface properties of metastatic tumor cells. Poste G; Nicolson GL Biomembranes; 1983; 11():341-64. PubMed ID: 6338950 [No Abstract] [Full Text] [Related]
7. Survey of mechanisms in electrochemical treatment (ECT) of cancer. Nordenström BE Eur J Surg Suppl; 1994; (574):93-109. PubMed ID: 7531033 [No Abstract] [Full Text] [Related]
8. On the failure of self-inhibition of growth in tumors. Burns ER Growth; 1969 Mar; 33(1):25-45. PubMed ID: 5790345 [No Abstract] [Full Text] [Related]
9. Cancer and ageing. Franks LM Acta Biol Acad Sci Hung; 1980; 31(1-3):97-105. PubMed ID: 7223247 [TBL] [Abstract][Full Text] [Related]
10. Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal. Shah N; Pang B; Yeoh KG; Thorn S; Chen CS; Lilly MB; Salto-Tellez M Eur J Cancer; 2008 Oct; 44(15):2144-51. PubMed ID: 18715779 [TBL] [Abstract][Full Text] [Related]
11. Putative transformation-dependent proteins in the blood plasma of tumor-bearing rats and cancer patients. Schumm DE; Webb TE Cancer Res; 1982 Dec; 42(12):4964-9. PubMed ID: 7139600 [No Abstract] [Full Text] [Related]
12. Control of differentiation in progression of epithelial tumors. Abelev GI; Lazarevich NL Adv Cancer Res; 2006; 95():61-113. PubMed ID: 16860656 [TBL] [Abstract][Full Text] [Related]
13. Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. Raught B; Gingras AC; James A; Medina D; Sonenberg N; Rosen JM Cancer Res; 1996 Oct; 56(19):4382-6. PubMed ID: 8813130 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Wright JA; Turley EA; Greenberg AH Crit Rev Oncog; 1993; 4(5):473-92. PubMed ID: 8241321 [TBL] [Abstract][Full Text] [Related]
15. Relative difficulties in transforming human and animal cells in vitro. DiPaolo JA J Natl Cancer Inst; 1983 Jan; 70(1):3-8. PubMed ID: 6571918 [No Abstract] [Full Text] [Related]
16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
17. A survey of intracellular Na+ and K+ of various normal, transformed, and tumor cells. Moyer MP; Moyer RC; Waite MR J Cell Physiol; 1982 Oct; 113(1):129-33. PubMed ID: 7130286 [TBL] [Abstract][Full Text] [Related]
18. [Rearrangements in cell populations in malignant growth]. Shuklinov VA Eksp Onkol; 1984; 6(6):25-30. PubMed ID: 6396066 [TBL] [Abstract][Full Text] [Related]